Loading insider details...
Beta
Latest Form 4 (Oct 7, 2026): Sale of 17,800 EBS shares, $126.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 7, 2026 | Emergent BioSolutions Inc. (EBS) | Sale | 17,800 | $126.2K |
| May 4, 2026 | Emergent BioSolutions Inc. (EBS) | Grant/Award | 25,344 | n/a |
| Nov 12, 2025 | Emergent BioSolutions Inc. (EBS) | Sale | 17,801 | $187.6K |
| Aug 13, 2025 | Emergent BioSolutions Inc. (EBS) | Sale | 7,844 | $67.8K |
| May 3, 2025 | Emergent BioSolutions Inc. (EBS) | Grant/Award | 34,403 | n/a |
| Nov 14, 2024 | Emergent BioSolutions Inc. (EBS) | Sale | 25,000 | $272.8K |
| May 29, 2024 | Emergent BioSolutions Inc. (EBS) | Grant/Award | 17,430 | n/a |
| Oct 5, 2023 | Emergent BioSolutions Inc. (EBS) | Grant/Award | 118,670 | n/a |